EPCAM and neoplasm: Additionally, a single-domain antibody against BAP31 was screened from a human phage antibody library and found to interfere with the formation of Sec61 and auxiliary translocon-associated protein (TRAP) complex, leading to significant anti-tumor effect both in vitro and in vivo by inhibiting N-glycosylation of EpCAM.